⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALXO News
ALX Oncology Holdings Inc. Common Stock
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas
globenewswire.com
ALXO
BNTX
Form 8-K
sec.gov
ALXO
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ALXO
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
globenewswire.com
ALXO